What Does It Mean to Have Enlarged Red Blood Cells?

Enlarged red blood cells, a finding doctors call macrocytosis, show up on routine blood work as a mean corpuscular volume (MCV) above 100 femtoliters.¹ It is not a disease in itself but a signal that something is influencing how your body produces or maintains its red blood cells. The causes range from vitamin deficiencies and alcohol use to thyroid dysfunction, liver disease, certain medications, and bone marrow disorders. Understanding what is driving the finding matters far more than the number alone, because the treatments and the urgency vary enormously depending on the cause.

How the Finding Shows Up on Blood Work

A standard complete blood count (CBC) includes MCV, which is essentially the average size of your red blood cells measured in femtoliters. When MCV climbs above 100, the lab flags it. A doctor reviewing a blood smear under a microscope can confirm this by looking for visibly oversized red blood cells and other clues, such as oddly shaped neutrophils (a type of white blood cell) or an unusually high number of young red blood cells called reticulocytes.² Those extra details help narrow down why the cells are enlarged. Some people with macrocytosis feel fine and discover it only on routine labs; others have fatigue, pallor, or shortness of breath because their enlarged cells are also fewer in number, meaning they have macrocytic anemia.

Vitamin B12 and Folate Deficiency

The textbook cause of macrocytosis is a shortage of vitamin B12 or folate. Both vitamins are essential building blocks for DNA synthesis. When either one is missing, developing red blood cells in the bone marrow struggle to replicate their DNA at a normal pace. The cell keeps growing while its nucleus falls behind, producing an oversized cell that is often oval-shaped rather than the usual disc.² Many of these abnormal precursor cells never make it out of the bone marrow alive; they self-destruct before release, which is why the resulting anemia can be severe.³

Folate deficiency tends to develop relatively quickly because the body stores only a few months’ worth. It is often linked to poor dietary intake, heavy alcohol use, or conditions that impair absorption in the small intestine. B12 deficiency can take years to appear since the liver stores enough to last a long time, but when it does, the consequences extend beyond the blood. One important cause of B12 deficiency is pernicious anemia, an autoimmune condition in which the body attacks the cells in the stomach lining that produce intrinsic factor, a protein required for B12 absorption. Diagnosing pernicious anemia can be tricky; in at least one documented case, autoantibodies interfered with the standard B12 lab test itself, nearly leading to a missed diagnosis.⁴

Alcohol and Liver Disease

Alcohol is one of the most common causes of enlarged red blood cells, and the mechanism is different from vitamin deficiency. Chronic alcohol use can raise MCV even when B12 and folate levels are normal. One of the ways this happens involves the liver. When the liver is damaged, its ability to manage lipid metabolism falters. Cholesterol accumulates in the membranes of circulating red blood cells, physically expanding their surface area and making them larger.⁵ This is not a problem with how the cells were built in the bone marrow; it is a change that happens to already-circulating cells because of abnormal blood chemistry.

In patients with hepatitis B-related cirrhosis, researchers found that macrocytic anemia was associated with the severity of liver impairment itself, with the cholesterol-deposition mechanism playing a significant role.⁶ For clinicians, a persistently elevated MCV in someone who drinks heavily can be a useful flag even before full-blown liver disease appears. It does not always mean the person is anemic, but it does suggest the liver and bone marrow are under stress.

Medications That Enlarge Red Blood Cells

A number of prescription drugs can push MCV above 100. The medications most commonly involved are those that interfere with DNA synthesis in a way that resembles a folate deficiency. Methotrexate, widely used for rheumatoid arthritis and certain cancers, is a well-studied example. In one study of rheumatoid arthritis patients, about one in five developed red blood cell macrocytosis over roughly three years of methotrexate use, and the change was persistent in about two-thirds of them. Interestingly, only a small fraction of those patients actually became anemic; the cells were bigger but the overall blood count often stayed acceptable.⁷ The likelihood of macrocytosis went up with higher methotrexate doses and when patients were simultaneously taking other drugs like sulfasalazine or leflunomide.

Other medications known to cause macrocytosis include certain anticonvulsants (like valproic acid and phenytoin), antiretroviral drugs used to treat HIV (particularly zidovudine), and chemotherapy agents such as hydroxyurea and azathioprine. In many of these cases, the elevated MCV is a predictable side effect rather than a sign of danger, but it still needs to be monitored because it can mask other problems. If a patient on methotrexate develops macrocytosis, the doctor needs to determine whether it is purely drug-related or whether an additional deficiency has crept in. In fact, one broader study found that drug therapy was the single most common explanation for macrocytosis when all causes were tallied, ahead of alcohol, liver disease, and high reticulocyte counts.⁸

Thyroid Dysfunction and Other Hormonal Links

Hypothyroidism, an underactive thyroid, has long been recognized as a cause of macrocytosis, though it does not get as much attention as vitamin deficiencies or alcohol. A large cross-sectional analysis using U.S. national health survey data found a clear relationship between thyroid hormone levels and red blood cell size: as levels of the thyroid hormones T3 and T4 went down, MCV went up. People in the highest MCV group had measurably lower thyroid hormone concentrations compared to those in the lowest MCV group.⁹ The mechanism is not entirely settled, but thyroid hormones help regulate how quickly bone marrow cells divide. When thyroid function drops, cell production slows, and red blood cells may spend longer maturing, emerging larger than normal.

This connection matters practically because hypothyroidism is common and treatable. If you have macrocytosis and your B12, folate, and liver function all look normal, a thyroid panel is a sensible next step. Treating the underlying thyroid condition typically brings MCV back into range over the course of several weeks to months as the bone marrow returns to its usual production pace.

Bone Marrow Disorders

Sometimes macrocytosis points to a problem in the bone marrow itself rather than a nutritional or metabolic cause. Myelodysplastic syndromes (MDS) are a group of conditions in which the bone marrow produces blood cells that are abnormal in shape, size, or number. These are clonal disorders, meaning they arise from mutations in a single bone marrow stem cell that then proliferates abnormally. MDS is characterized by ineffective blood cell production, with the bone marrow working hard but turning out defective products, leading to low blood counts and often visibly enlarged or misshapen red blood cells.¹⁰

MDS is far less common than vitamin deficiency or alcohol-related macrocytosis, and it overwhelmingly affects older adults. But it is the cause doctors are most concerned about missing, because some forms can progress to acute leukemia. Diagnosing MDS requires a bone marrow biopsy; a standard blood test can raise suspicion but cannot confirm it. If macrocytosis persists after the usual nutritional and metabolic causes have been ruled out, particularly in someone over 60 with unexplained low blood counts, a bone marrow examination is typically the next step.

When Larger Cells Are Actually a Good Sign

Not every case of macrocytosis signals a problem. After significant blood loss or during recovery from anemia, the bone marrow ramps up production and releases reticulocytes, which are young red blood cells that are naturally larger than mature ones. A burst of reticulocytes entering the bloodstream can push the average MCV above 100 even though the individual mature cells are normal-sized. This is actually a healthy response showing that the bone marrow is doing its job. A reticulocyte count can quickly sort this out; if it is elevated, the macrocytosis is likely reactive rather than pathological.

Pregnancy also shifts blood parameters in ways that can mimic disease. Blood volume expands significantly during pregnancy, red blood cell production increases, and physiological changes to the blood can raise MCV modestly.¹¹ Pregnant women are also at higher risk for genuine folate deficiency if they are not supplementing, so an elevated MCV during pregnancy deserves investigation but does not automatically indicate a serious problem.

The Difference Between Macrocytosis and Macrocytic Anemia

A distinction that often gets blurred in everyday conversation is the one between macrocytosis (enlarged red blood cells) and macrocytic anemia (enlarged red blood cells combined with a low hemoglobin count). You can have macrocytosis without being anemic. As the methotrexate study showed, only about a fifth of patients with drug-induced macrocytosis actually had anemia alongside it.⁷ Many people with mild, stable macrocytosis from moderate alcohol use or a medication side effect feel perfectly well and have normal hemoglobin.

This matters because the urgency of the workup depends partly on whether anemia is present. Isolated macrocytosis in an otherwise healthy person with an obvious explanation (say, a known medication) may just need monitoring. Macrocytic anemia, especially when it develops quickly or is accompanied by symptoms like fatigue, numbness, or cognitive changes, warrants a more thorough investigation sooner.

Neurological Consequences of B12 Deficiency

One of the most important reasons not to dismiss macrocytosis as trivial is the potential for nerve damage from prolonged B12 deficiency. B12 is required to maintain the myelin sheath that insulates nerve fibers in the spinal cord and brain. When the deficiency persists, a condition called subacute combined degeneration can develop, causing numbness and tingling in the hands and feet, difficulty walking, impaired balance, and even visual changes.¹² This neurological damage can become irreversible if it goes untreated for too long.

The unsettling part is that neurological symptoms from B12 deficiency can appear before any obvious changes in the blood. Some people develop numbness, memory problems, or mood disturbances while their MCV is still normal or only mildly elevated. Conversely, a person with significantly enlarged red blood cells from B12 deficiency may have no neurological complaints at all. The two systems, blood and nerves, do not always decline in lockstep. This is one reason many clinicians check B12 levels proactively when macrocytosis appears, rather than waiting for neurological symptoms to show up.

What the Diagnostic Workup Looks Like

When a doctor encounters macrocytosis on a CBC, the evaluation typically unfolds in stages. The first round of testing usually includes a blood smear review, liver function tests, B12 and folate levels, and sometimes additional markers like methylmalonic acid and homocysteine, which can detect B12 deficiency even when the standard B12 level is borderline.⁸ A reticulocyte count helps determine whether the bone marrow is releasing an excess of young cells, and a thyroid panel is often included as well.

If these initial tests point toward a vitamin deficiency, treatment with supplements or injections usually follows, and repeat blood work a few weeks later confirms whether MCV is trending back down. If the usual suspects come back negative and macrocytosis persists, the investigation moves to the bone marrow itself. A biopsy can reveal conditions like MDS that are invisible on standard blood tests.¹⁰ The timeline varies: a mild, stable MCV elevation in a 30-year-old on methotrexate might warrant nothing more than periodic monitoring, while a progressive rise in MCV with worsening blood counts in a 70-year-old would move to biopsy fairly quickly.

How Red Blood Cell Width Adds Context

MCV tells you the average size of your red blood cells, but averages can be misleading. A second measurement called the red cell distribution width (RDW) captures how much variation exists among the cells. A high RDW means the cells are a mix of sizes, while a normal RDW means they are mostly uniform. This distinction helps with diagnosis. In folate deficiency, for instance, models show that both normal and abnormally large red blood cells circulate together during the early phase of the deficiency and during recovery, producing a high MCV alongside a high RDW.¹³ In contrast, alcohol-related macrocytosis often produces uniformly large cells with a relatively normal RDW. The combination of MCV and RDW, both of which are included on a standard CBC, gives the doctor a more complete picture without requiring any additional blood draw.

RDW also helps distinguish situations where two problems coexist. Someone with both iron deficiency (which makes cells small) and B12 deficiency (which makes them large) might have a deceptively normal MCV because the two effects cancel each other out on average. But the RDW would be strikingly high because you have two distinct populations of abnormally sized cells. Recognizing this pattern prevents a dual deficiency from slipping through unnoticed.

Pernicious Anemia and Its Particular Challenges

Pernicious anemia deserves its own discussion because it represents a specific, lifelong form of B12 deficiency with unique diagnostic hurdles. The condition was historically fatal before B12 injections became available, hence the name “pernicious.” It is caused by destruction of the stomach’s parietal cells, which produce intrinsic factor. Without intrinsic factor, oral B12 cannot be absorbed properly, no matter how much you eat.¹⁴

One practical trap with pernicious anemia is that certain autoantibodies in the patient’s blood can interfere with the laboratory assay used to measure B12, producing a falsely normal result. This has led to cases where patients with classic symptoms of B12 deficiency and macrocytic anemia were initially steered toward more invasive testing for other conditions before the true diagnosis was recognized.⁴ If your doctor suspects pernicious anemia but your B12 level looks reassuringly normal, additional tests such as methylmalonic acid, homocysteine, and intrinsic factor antibodies can uncover the deficiency that the standard test missed. Once diagnosed, treatment typically involves B12 injections rather than oral supplements, since the core problem is absorption.

Living With Macrocytosis on Long-Term Medications

For people who need to stay on a medication that raises MCV, the question shifts from “how do I fix this?” to “how do I manage this safely?” Methotrexate is again a good example. Doctors routinely prescribe folic acid alongside methotrexate to partially offset its effects on DNA synthesis, but this does not always prevent macrocytosis from developing. In the rheumatoid arthritis study, the occurrence of macrocytosis was tied to the methotrexate dose and to the use of additional immunosuppressive medications.⁷ In some cases, patients who developed macrocytosis were more likely to be transitioned to newer biologic therapies, partly because the macrocytosis signaled that the drug was hitting the bone marrow harder than desired.

The key for people on these medications is regular monitoring. A gradually rising MCV that is tracked over time tells a very different story from one that spikes suddenly. A slow, stable increase may be an acceptable trade-off for a medication that is controlling a serious illness. A rapid jump, or a drop in hemoglobin or white blood cell count alongside rising MCV, is a more urgent signal that the medication regimen may need adjustment. Keeping up with scheduled blood work, even when you feel fine, is what gives your doctor the data to make that call before symptoms develop.

1
PubMed Central. Evaluation of macrocytosis in routine hemograms
2
PubMed Central. Megaloblastic anemia and other causes of macrocytosis
3
PubMed. Apoptosis in megaloblastic anemia occurs during DNA synthesis by a p53-independent, nucleoside-reversible mechanism
4
PubMed Central. Autoantibodies to intrinsic factor can jeopardize pernicious anemia diagnosis: a case report
5
Advances in Clinical and Experimental Medicine. Rare causes of anemia in liver diseases
6
BMC Gastroenterology. Macrocytic anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis
7
PubMed Central. An erythrocyte macrocytosis by methotrexate is associated with early initiation of biologic or targeted synthetic agents in patients with rheumatoid arthritis
8
PubMed. Etiology and diagnostic evaluation of macrocytosis
9
PubMed Central. Associations among thyroid hormone levels and mean corpuscular volume in adults in the US
10
PubMed Central. How we diagnose Myelodysplastic syndromes
11
PubMed Central. Physiological changes in hematological parameters during pregnancy
12
PubMed Central. Clinical Presentation of Subacute Combined Degeneration in a Patient With Chronic B12 Deficiency
13
BioMed Central / Theoretical Biology and Medical Modelling. Predicting iron and folate deficiency anaemias from standard blood testing
14
PubMed Central. Recognizing, treating and understanding pernicious anaemia